Avicenna Alliance: enhanced knowledge, improved decisions, better outcomes
FULL MENU

Our Team

People of Avicenna Alliance


Thierry Marchal

Thierry Marchal

Avicenna Alliance President and Secretary General

Program Director for Healthcare Solution, ANSYS, Inc.

SEND E-MAIL
READ BIO
Roberta Maggi

Roberta Maggi

Avicenna Alliance Office Manager

Avicenna Alliance

SEND E-MAIL +39.351.8890319
READ BIO
Mathieu Rimaud

Mathieu Rimaud

Avicenna Alliance Treasurer

CEO, TwInsight

SEND E-MAIL
READ BIO
Cécile Rousseau

Cécile Rousseau

In Silico Application Working Group Leader

Senior Director, Nonclinical & Early Clinical Development, VCLS

SEND E-MAIL
READ BIO
Emmanuelle Voisin

Emmanuelle Voisin

In Silico Application Working Group Leader

Founder & CEO, Voisin Consulting Life Sciences (VCLS)

SEND E-MAIL
READ BIO
Liesbet Geris

Liesbet Geris

Research & Technology Working Group Leader

Executive Director, VPH Institute

SEND E-MAIL
READ BIO
Martha De Cunha Maluf-Burgman

Martha De Cunha Maluf-Burgman

Policy Development Working Group Leader

Director Regulatory Affairs, Edwards Lifesciences

SEND E-MAIL
READ BIO
Marc Horner

Marc Horner

Leader of the International Affairs WG & Chair of the Global Harmonization TF

Distinguished Engineer, Ansys

READ BIO

NEWS

News Welcome on Board, Hemolens Diagnostics!

Welcome on Board, Hemolens Diagnostics!

We are delighted to welcome Hemolens Diagnostics as a new member of the Avicenna Alliance!

News Poll on Computer Modelling & Simulation

Poll on Computer Modelling & Simulation

The Avicenna Clinical Deployment Task Force, led by Co-Chairs Erica Beaucage-Gauvreau & René Bombien, is engaged to grow a network of professionals with expertise in clinical applications of in silico methodologies, to foster collaboration and knowledge exchange.

News April 8th - Avicenna Webinar on ERAMET: Advancing Orphan & Paediatric Drug Development

April 8th - Avicenna Webinar on ERAMET: Advancing Orphan & Paediatric Drug Development

Join Next Avicenna Webinar on ERAMET: Advancing Orphan & Paediatric Drug Development! The EU-funded ERAMET project is transforming how orphan and paediatric medicines are developed. By integrating advanced Computational Modelling & Simulation (CM&S) techniques with real-world data, ERAMET is building a transparent ecosystem to support both medicine developers and regulators.

Sign up for our monthly newsletter!

Sign up for our monthly newsletter!

Fill in the fields you find below

Avicenna Alliance is an initiative of:

Avicenna VPH

© 2018-2025 Avicenna Alliance | powered by We Berry